Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches.
Gokhan Burcin KubatPasquale PiconePublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2024)
Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neuromuscular disease that results in the loss of motor neurons and severe skeletal muscle atrophy. The etiology of ALS is linked to skeletal muscle, which can activate a retrograde signaling cascade that destroys motor neurons. This is why satellite cells and mitochondria play a crucial role in the health and performance of skeletal muscles. This review presents current knowledge on the involvement of mitochondrial dysfunction, skeletal muscle atrophy, muscle satellite cells, and neuromuscular junction (NMJ) in ALS. It also discusses current therapeutic strategies, including exercise, drugs, stem cells, gene therapy, and the prospective use of mitochondrial transplantation as a viable therapeutic strategy.
Keyphrases
- skeletal muscle
- amyotrophic lateral sclerosis
- induced apoptosis
- insulin resistance
- stem cells
- oxidative stress
- gene therapy
- cell cycle arrest
- healthcare
- spinal cord
- cell death
- multiple sclerosis
- public health
- mental health
- cell therapy
- type diabetes
- metabolic syndrome
- reactive oxygen species
- health information
- adipose tissue
- social media
- pi k akt
- bone marrow